Company Monitoring Page for Vanda

latest headlines for company on cafepharma

EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda
RAPS.org
Sat, 07/22/17 - 12:23 pm
Tags:
EMA, Europe, Pfizer, Bavencio, Novartis, Rydapt, Lexicon Pharmaceuticals, Xermelo, Vanda, Fanaptum, Nektar, Onzeald, Daiichi Sankyo
3 Small-Cap Biotechs That Institutions Are Loving
Yahoo/Benzinga
Mon, 07/7/14 - 07:30 pm
Tags:
Infinity Pharmaceuticals, Vanda, Lexicon Pharmaceuticals
Tuesday’s Top Biotech Stories: Vanda Pharmaceuticals, Prosensa, and Clovis Oncology
Motley Fool
Tue, 06/3/14 - 11:38 am
Tags:
Vanda, Prosensa, Clovis Oncology, Hetlioz, CO-1686, drisapersen
Vanda Pharmaceuticals Wins FDA Approval of Sleep Disorder Drug
Wall St Cheat Sheet
Sat, 02/1/14 - 10:44 am
Tags:
Hetlioz, Vanda, sleep aid, hypnotics
Will the FDA Approve Vanda's Hetlioz?
Motley Fool
Tue, 01/28/14 - 11:54 am
Tags:
Vanda, FDA, Hetlioz, non-24 hour disorder
2014 Biotechnology Catalysts
Seeking Alpha
Fri, 01/10/14 - 08:14 am
Tags:
Chelsea Therapeutics, Durect Corporation, EXACT Sciences, Vanda, Pozen, Progenics, MannKind, FDA
22 Biotech Stock Predictions for 2014
TheStreet.com
Mon, 01/6/14 - 09:47 am
Tags:
biotech, Vertex Pharmaceuticals, Orexigen, Retrophin, Valeant Pharmaceuticals, Questcor, Biomarin, Merck, NeoStem, Amgen, Gilead Sciences, Vanda, Keryx, Peregrine Pharmaceuticals, CelSci, Regeneron, Cempra, Dendreon, Clovis Oncology, Halozyme, NPS Pharmaceuticals
2014 FDA Drug Approval Decision Calendar
TheStreet.com
Wed, 11/27/13 - 08:39 am
Tags:
FDA, drug approvals, GSK, Gilead, Theravance, Auxilium, Amarin, Bristol-Myers Squibb, Biogen Idec, Pozen, Vanda, Chelsea Therapeutics, pSivida, Alimera, United Therapeutics, Biomarin, JNJ, Pharmacyclics, Celgene, MannKind, Santarus, AstraZeneca, Durata Therapeutics, Eli Lilly, Omeros, BioDelivery Sciences, Anacor, Keryx, Cubist Pharmaceuticals, Nektar
Biotech Stock Roundup: Vanda Soars, Sarepta Slumps
Yahoo/Zacks.com
Wed, 11/20/13 - 11:47 am
Tags:
Vanda, Sarepta Therapeutics, tasimelteon, Hetlioz, Duchenne Muscular Dystrophy, eteplirsen
Amarin, Sarepta And Vanda: Teachable Moments In Biotech
Seeking Alpha
Sun, 11/17/13 - 12:13 pm
Tags:
Amarin, Sarepta, Vanda
This Week in Biotech
Motley Fool
Sat, 11/16/13 - 01:23 pm
Tags:
Vanda, Cadence Pharmaceuticals, Immunogen, Novartis, Pharmacyclics, JNJ, Epizyme, Sarepta Therapeutics, GSK
U.S. FDA panel backs Vanda's circadian rhythm drug
Yahoo/Reuters
Thu, 11/14/13 - 05:50 pm
Tags:
FDA, advisory panels, Vanda, non-24 hour disorder, tasimelteon
Vanda Pharma FDA Panel Live Blog
TheStreet.com
Thu, 11/14/13 - 08:53 am
Tags:
Vanda, FDA, advisory panels, tasimelteon, non-24 hour disorder, blindness
FDA reviewer recommends approval of Vanda sleep drug for blind
The Fly on the Wall
Tue, 11/12/13 - 08:52 am
Tags:
FDA, Vanda, non-24 hour disorder, tasimelteon
Upcoming Catalysts Should Provide Strong Upside For These BioPharma Companies
Seeking Alpha
Fri, 10/18/13 - 10:51 am
Tags:
Celldex, ImmunoCellular Therapeutics, Enanta, Merrimack Pharmaceuticals, Vanda
More Trouble For Vanda's Sleep Disorder Drug
TheStreet.com
Wed, 08/7/13 - 09:47 am
Tags:
Vanda, tasimelteon, non-24 hour disorder
Vanda Pharmaceuticals Reports Second Quarter 2013 Results
Yahoo/PR Newswire
Wed, 07/31/13 - 09:13 am
Tags:
Vanda, earnings
Vanda says Phase III study data shows cortisol rhythm restoration
Yahoo/Fly on the Wall
Tue, 06/18/13 - 09:52 am
Tags:
Vanda, cortisol, tasimelteon, non-24 hour disorder
Vanda files for approval of sleep disorder drug
Yahoo/AP
Fri, 05/31/13 - 01:01 pm
Tags:
Vanda, tasimelteon
Why Did Vanda Pharmaceuticals Hit A 52-Week High?
Seeking Alpha
Fri, 04/19/13 - 08:49 am
Tags:
Vanda, Sanofi, Novartis, Eli Lilly, tasimelteon, Fanapt

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.